Quinuclidines as selective agonists for alpha-7 nicotinic acetylcholine receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 6, 2007, Pages 1520-1522

  Leonik, Fedra M ^a   Papke, Roger L ^b   Horenstein, Nicole A ^a  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Acetylcholine; Agonist; nAChR; Nicotinic; Olefination; Quinuclidine; Receptor

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ARR 17779; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7; NICOTINIC AGENT; NICOTINIC RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; QUINUCLIDINE DERIVATIVE; RECEPTOR SUBTYPE; TC 1698; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL INTERACTION; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG TARGETING; HYDROPHOBICITY; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; NICOTINIC AGONISTS; OOCYTES; QUINUCLIDINES; RECEPTORS, NICOTINIC; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS;

EID: 33847038273     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.01.003     Document Type: Article

References (19)

1. Itier V., and Bertrand D. FEBS Lett. 504 (2001) 118
2. Clarke P.B.S., Schwartz R.D., Paul S.M., Pert C.B., and Pert A. J. Neurosci. 5 (1985) 1307
3. Oddo S., and LaFerla F.M. J. Physiol. Paris 99 (2006) 172
4. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nature 421 (2003) 384
5. Meyer E.M., Kuryatov A., Gerzanich V., Lindstrom J., and Papke R.L. J. Pharmacol. Exp. Ther. 287 (1998) 918
6. Glennon R.A., Dukat M., and Liao L. Curr. Top. Med. Chem 4 (2004) 631
7. Cashin A.L., Petersson E.J., Lester H.A., and Dougherty D.A. J. Am. Chem. Soc. 127 (2005) 350
8. Meyer E.M., Tay E.T., Papke R.L., Meyers C., Huang G.L., and deFiebre C.M. Brain Res. 768 (1997) 49
9. Marrero M.B., Papke R.L., Bhatti B.S., Shaw S., and Bencherif M. J. Pharmacol. Exp. Ther. 309 (2004) 16
10. Mullen G., Napier J., Balestra M., DeCory T., Hale G., Macor J., Mack R., Loch J., Wu E., Kover A., Verhoest P., Sampognaro A., Phillips E., Zhu Y.Y., Murray R., Griffith R., Blosser J., Gurley D., Machulskis A., Zongrone J., Rosen A., and Gordon J. J. Med. Chem. 43 (2000) 4045
11. Papke R.L., Bencherif M., and Lippiello P. Neurosci. Lett. 213 (1996) 201
12. Stokes C., Porter-Papke J.K., Horenstein N.A., Kem W.R., McCormack T.J., and Papke R.L. Mol. Pharmacol. 66 (2004) 14
13. Papke R.L., Schiff H.A., Jack B.A., and Horenstein N.A. Neurosci. Lett. 378 (2005) 140
14. Papke R.L. Life Sci. 78 (2006) 2812
15. Morgan T.K., Lis R., Marisca A.J., Argentieri T.M., Sullivan Me., and Wong S.S. J. Med. Chem. 30 (1987) 2259
16. Ishihara T., Kakuta H., Moritani H., Ugawa T., Sakamoto S., Tsukamoto S., and Yanagisawa I. Bioorg. Med. Chem. Lett. 11 (2003) 2403
17. Stotter P.L., Friedman M.D., Dorsey G., Shiely R.W., Williams R.F., and Minter D.E. Heterocycles 25 (1987) 251
18. Wadsworth W.S., and Emmons W.D. J. Am. Chem. Soc. 83 (1961) 1733
19. Horenstein, N. A.; Leonik, F. M.; Papke, R. L. to be submitted.